George Acquaah-Mensah
Professor of Pharmaceutical Sciences
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (11)
Year:
2026
Background/Objectives: Breast cancer (BrCA) is among the deadliest cancers for women in the world. The disease has four distinct molecular subtypes which can be determined by gene expression profiling. Understanding these subtypes has enabled the development of targeted therapeutics. Additionally, following initial successful treatment, some patients experience disease recurrence events. Methods: In this study, we used radiomics coupled with machine learning techniques to predict molecular subtypes and disease recurrence events from a dataset of MRI features deriving from a single-institutional, retrospective collection of 922 biopsy-confirmed invasive BrCA patients. The feature-rich and comprehensive dataset consists of radiomic as well as demographic, clinical, and molecular subtype information. We focused our analyses on Black and White patients who were 50 years or younger at diagnosis (n = 346) to identify racial disparities that exist between molecular subtypes and disease recurrence events. Random Forest and AdaBoostM1 were applied to over 500 radiomics features. Results: Radiomics alone or combined with gene expression data can accurately predict molecular subtype and disease recurrence events for both racial groups. In total, we found over 40 radiomics features that have significant associations with race. The radiomic features that are most predictive in the Breast and Fibroglandular Tissue Volume imaging category for Black patients was breast volume (Breast_Vol) and for White patients was post contrast tissue volume (TissueVol_PostCon). Conclusions: These results suggest that radiomics can be used to predict differences in BrCA recurrence and molecular subtype between racial groups and can have an impact on clinical outcomes.
Year:
2025
Lung cancer, the leading cause of cancer mortality, exhibits diverse histologic subtypes and genetic complexities. Numerous preclinical mouse models have been developed to study lung cancer, but data from these models are disparate, siloed, and difficult to compare in a centralized fashion. In this study, we established the Lung Cancer Autochthonous Model Gene Expression Database (LCAMGDB), an extensive repository of 1,354 samples from 77 transcriptomic datasets covering 974 samples from genetically engineered mouse models (GEMM), 368 samples from carcinogen-induced models, and 12 samples from a spontaneous model. Meticulous curation and collaboration with data depositors produced a robust and comprehensive database, enhancing the fidelity of the genetic landscape it depicts. The LCAMGDB aligned 859 tumors from GEMMs with human lung cancer mutations, enabling comparative analysis and revealing a pressing need to broaden the diversity of genetic aberrations modeled in the GEMMs. To accompany this resource, a web application was developed that offers researchers intuitive tools for in-depth gene expression analysis. With standardized reprocessing of gene expression data, the LCAMGDB serves as a powerful platform for cross-study comparison and lays the groundwork for future research, aiming to bridge the gap between mouse models and human lung cancer for improved translational relevance. Significance: The Lung Cancer Autochthonous Model Gene Expression Database (LCAMGDB) provides a comprehensive and accessible resource for the research community to investigate lung cancer biology in mouse models.
Year:
2025
Year:
2023
Year:
2022
Year:
2022
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Collaborators (24)
Kekoa Taparra
Assistant Professor
University of California, Los Angeles
John Minna
Professor and Direcdtor
University of Texas Southwestern Medical Center
Vassilis Aidinis
Biomedical Sciences Research Center Alexander Fleming
Barbara Grüner
University Hospital Essen
Phuoc T. Tran
University of Maryland
Pawel Mazur
Associate Professor
The University of Texas MD Anderson Cancer Center
Roger A. Moorehead
University of Guelph
Ralph J. DeBerardinis
University of Texas Southwestern Medical Center
Charles Rudin
Memorial Sloan Kettering Cancer Center
J. Edward van Veen
Assistant Adjunct Professor
University of California, Los Angeles
Yonathan Lissanu
The University of Texas MD Anderson Cancer Center
Trudy G. Oliver
Duke University
YING GAO
University of Texas Southwestern Medical Center
David MacPherson
Professor
Fred Hutch Cancer Center
Giorgio Ramadori
Scientific Collaborator
University of Geneva
Rosanna Martinelli
Professor of Molecular Biology
Università degli Studi di Napoli Federico II
Min Gyu Lee
Professor
The University of Texas MD Anderson Cancer Center
Florian Gnad
Head
Roche Diagnostics
Shyam Biswal
Professor
Johns Hopkins University
Arun Pandiri
Staff Scientist
National Institute of Environmental Health Sciences
CHARLES POWELL
Division Chief/Professor of Medicine
Icahn School of Medicine at Mount Sinai
Jennifer Beane-Ebel
Assistant Professor
Boston University School of Medicine
Guanghua Xiao
-
Yang Xie
Professor
University of Texas Southwestern Medical Center
Make your next move.
Prepare your application
Review drafts before you send them.